SEC Form 4 · accession 0001562180-19-001223
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Malone
Officer — Vice President & Controller
Period of report
Feb 19, 2019
Accepted (ET)
Feb 21, 2019 · 7:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 19, 2019 | A | 1,281 | $102.51 | A | 6,735 | I | Non-Qualified Deferred Compensation Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F2 | $102.51 | Feb 19, 2019 | A | 3,060 | A | Feb 19, 2020 | Feb 19, 2029 | Common Stock | 3,060 | 3,060 | D |
Explanation of responses
- F12016 PSUs (PP15) award vesting.
- F2This award vests in four equal annual installments beginning on February 19, 2020.